Also trades as: FSNUY (OTC) · $vol 2M · FSNUF (OTC) · $vol 0M · FRE.SW (SIX) · $vol 0M

€43.63 ($49.10)

-0.17 (-0.38%)

Weekly Expected Move ±3.9%

€40 €42 €44 €45 €47

XETRA · Healthcare · Medical - Care Facilities · Tech Score Strong Sell · Power 37 · €24.6B mcap · 411M float · 0.278% daily turnover

Revenue

$22.9B +4.8% ▲

5Y CAGR: -8.8%

Gross Profit

$5.7B +5.9% ▲

5Y CAGR: -11.2%

Operating Income

$2.2B +18.6% ▲

5Y CAGR: -13.1%

Net Income

$1.3B +168.4% ▲

5Y CAGR: -5.8%

EPS (Diluted)

$2.24 +166.7% ▲

5Y CAGR: -6.0%

EBITDA

$3.3B +8.5% ▲

5Y CAGR: -14.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$37.5B	$40.8B	$22.3B	$21.8B	$22.9B
YoY Growth	+3.4%	+8.8%	-45.4%	-2.1%	+4.8%
Cost of Revenue	$27.2B	$30.1B	$17.2B	$16.5B	$17.2B
Gross Profit	$10.3B	$10.7B	$5.1B	$5.4B	$5.7B
Gross Margin	27.5%	26.3%	22.7%	24.6%	24.9%
R&D Expenses	$805M	$867M	$661M	$641M	$633M
SG&A Expenses	$5.5B	$6.7B	$3.2B	$2.9B	$2.9B
Operating Expenses	$6.2B	$7.4B	$3.9B	$3.6B	$3.5B
Operating Income	$4.2B	$3.5B	$1.1B	$1.8B	$2.2B
Operating Margin	11.1%	8.6%	5.1%	8.2%	9.5%
Interest Expense	$630M	$345M	$534M	$547M	$438M
Income Before Tax	$3.7B	$2.8B	$715M	$1.4B	$2.2B
Tax Expense	$833M	$697M	$477M	$521M	$582M
Net Income	$1.8B	$1.4B	-$594M	$471M	$1.3B
Net Margin	4.8%	3.4%	-2.7%	2.2%	5.5%
EPS (Diluted)	$3.26	$2.44	$-1.05	$0.84	$2.24
EBITDA	$6.8B	$3.1B	$2.7B	$2.9B	$3.3B
Shares Outstanding	558M	561M	563M	563M	563M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$5.4B	$5.6B	$5.7B	$5.6B	$5.5B	$6.2B	$5.8B	$5.9B
Cost of Revenue	$4.0B	$4.2B	$4.2B	$4.1B	$4.2B	$4.6B	$4.3B	$4.4B
Gross Profit	$1.4B	$1.4B	$1.4B	$1.5B	$1.3B	$1.5B	$1.5B	$1.6B
Gross Margin	25.4%	25.1%	25.0%	26.1%	23.7%	24.8%	26.4%	26.1%
R&D Expenses	$170M	$177M	$140M	$164M	$159M	$170M	$163M	$167M
SG&A Expenses	$701M	$733M	$643M	$740M	$676M	$824M	$743M	$760M
Operating Expenses	$871M	$946M	$724M	$898M	$835M	$994M	$906M	$927M
Operating Income	$492M	$469M	$687M	$560M	$465M	$530M	$629M	$623M
Operating Margin	9.2%	8.3%	12.2%	10.0%	8.5%	8.6%	10.8%	10.5%
Interest Expense	$116M	$96M	$81M	$86M	$81M	$81M	$69M	$73M
Income Before Tax	$415M	$401M	$611M	$491M	$479M	$607M	$577M	$535M
Tax Expense	$96M	$130M	$140M	$146M	$116M	$180M	$132M	$136M
Net Income	$326M	$240M	$229M	$330M	$344M	$361M	$435M	$382M
Net Margin	6.1%	4.3%	4.1%	5.9%	6.3%	5.9%	7.5%	6.4%
EPS (Diluted)	$0.58	$0.43	$0.41	$0.58	$0.61	$0.64	$0.82	$0.68
EBITDA	$757M	$795M	$949M	$828M	$741M	$1.0B	$919M	$882M
Shares Outstanding	562M	563M	563M	569M	563M	563M	561M	563M

FRE.DE XETRA